Patent ID: 8580710
Filing Date: 2013-11-12
Classification: A01N,A61P

Abstract:
1. A pesticidal mixture comprising as active compounds 1) at least one aminothiazoline compound I of formula I: wherein R R R R with the proviso that R or the tautomers, enantiomers, diastereomers or salts thereof, and 2) at least one active compound II selected from group A consisting of A.1 an acetylcholine esterase inhibitor selected from the group consisting of triazamate and from the class of carbamates consisting of aldicarb, alanycarb, benfuracarb, carbaryl, carbofuran, carbosulfan, methiocarb, methomyl, oxamyl, primicarb, propoxur and thiodicarb, or from the class of organophosphates consisting of acephate, azinphos-ethyl, azinphos-methyl, chlorfenvinphos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, demeton-S-methyl, diazinon, dichlorvos/DDVP, dicrotophos, dimethoate, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, isoxathion, malathion, methamidaphos, methidathion, mevinphos, monocrotophos, oxymethoate, oxydemeton-methyl, parathion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, pirimiphos-methyl, quinalphos, terbufos, tetrachlorvinphos, triazophos trichlorfon, and vamidothion; A.2 a GABA-gated chloride channel antagonist selected from the group consisting of cyclodiene organochlorine endosulfan, chlordane, lindane, N-Ethyl-2,2-dimethylpropionamide-2-(2,6-dichloro-α.α.α-trifluoro-p-tolyl)hydrazon, N-Ethyl-2,2-dichloro-1-methylcyclopropane-carboxamide-2-(2,6-dichloro-α.α.α-trifluoro-p-tolyl) hydrazon, and a compound from the class of phenylpyrazoles consisting of acetoprole, ethiprole, fipronil, pyrafluprole, pyriprole, vaniliprole and the phenylpyrazole compound II.A A.3 a sodium channel modulator selected from the class of pyrethroids consisting of acrinathrin, allethrin, d-cis-trans-allethrin, d-trans-allethrin, bifenthrin, bioallethrin, bioallethrin S-cyclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, zeta-cypermethrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flumethrin, flucythrinate, tau-fluvalinate, halfenprox, imiprothrin, permethrin, phenothrin, prallethrin, profluthrin, pyrethrin (pyrethrum), resmethrin, silafluofen tefluthrin, tetramethrin, transfluthrin, and tralomethrin; A.4 a narcotic acteylcholine receptor agonist/antagonist selected from the group consisting of nicotine, bensultap, cartap hydrochloride, thiosultap-sodium or thiocyclam or from the class of neonicotinoids consisting of acteamiprid, chlothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid, thiamethoxam and AKD-1022; or the allosteric nicotinic acteylcholine receptor agonists spinosad and spinetoram; A.5 a chloride channel activator selected from the group consisting of abamectin, emamectin benzoate, lepimectin and milbemectin; A.6 a juvenile hormone mimic selected from the group consisting of hydroprene, kinoprene, fenoxycarb and pyriproxyfen; A.7 a compound affecting the oxidative phosphorylation selected from the group consisting of azocyclotin, cyhexatin, diafenthiuron, fenbutatin oxide, propargite and chlorfenapyr; A.8 an inhibitor of the chitin biosynthesis selected from the group consisting of buprofezin and from the class of benzylureas consisting of bistrifluoron, chlorfluazuron diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, noviflumuron, novaluron, teflubenzuron, and triflumuron; A.9 a moulting disruptor selected from the group consisting of cyromazine and from the class of ecdysone agonists consisting of methoxyfenozide, tebufenozide and azadirachtin; A.10 a mitochondrial electron transport-inhibitor selected from the group consisting of fenazaquin, fenproximate, pyrimidifen, pyridaben, tolfenpyrad, flufenerim and rotenone; A.11 a voltage-dependent sodium channel blocker selected from the group consisting of indoxacarb and metaflumizone; A.12 an inhibitor of the lipid synthesis selected from the group consisting of spirodiclofen, spiromesifen and spirotetramat; A.13 a fumigant selected the group consisting of methyl bromide and chloropicrin sulfuryl fluoride; A.14 a selective feeding blocker selected from the group consisting of crylotine, pymetrozine, and flonicamid; A.15 a mite growth inhibitor selected from the group consisting of clofentezine, hexythiazox, and etoxazole; A.16 Octapaminergic agonist amitraz; A.17 a Ryanodine receptor modulator selected from the group consisting of flubendiamide; and (R)- or (S)-3-chloro-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamide (A17.1); A.18 an anthranilamide selected from the group consisting of chloranthraniliprole, cyantraniliprole, 5-Bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3-carboxylic acid [4-cyano-2-(1-cyclopropyl-ethylcarbamoyl)-6-methyl-phenyl]-amide (A18.1), 5-Bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3-carboxylic acid [2-chloro-4-cyano-6-(1-cyclopropyl-ethylcarbamoyl)-phenyl]-amide (A 18.2), 5-Bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3-carboxylic acid [2-bromo-4-cyano-6-(1-cyclopropyl-ethylcarbamoyl)-phenyl]-amide (A18.3), 5-Bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3-carboxylic acid [2-bromo-4-chloro-6-(1-cyclopropyl-ethylcarbamoyl)-phenyl]-amide (A18.4), 5-Bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3-carboxylic acid [2,4-dichloro-6-(1-cyclopropyl-ethylcarbamoyl)-phenyl]-amide (A18.5), and 5-Bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3-carboxylic acid [4-chloro-2-(1-cyclopropyl-ethylcarbamoyl)-6-methyl-phenyl]-amide (A18.6); A.19 a microbial disruptor selected from the group consisting of A.20 A group of various compounds consisting of aluminium phosphide, amidoflumet, benzoximate, bifenazate, borax, bromopropylate, cinomethionate, cyanide, clofentezine, cyenopyrafen, cyflumetofen, dicofol, etoxazole, flonicamid, flupyrazophos, fluoroacetate, hexythiazox, phosphine, sulfur, sulfoxaflor, pymetrozine, pyridalyl, pyrifluquinazon, 4-But-2-ynyloxy-6-(3,5-dimethyl-piperidin-1-yl)-2-fluoro-pyrimidine (A20.1), 3-Benzoylamino-N-[2,6-dimethyl-4-(1,2,2,2-tetrafluoro-1-trifluoromethyl-ethyl)-phenyl]-2-fluoro-benzamide (A20.2), 4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N-pyridin-2-ylmethyl-benzamide (A20.3), 4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N-(2,2,2-trifluoro-ethyl)-benzamide (A20.4), 4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N-thiazol-2-ylmethyl-benzamide (A20.5), 4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N-(tetrahydro-furan-2-ylmethyl)-benzamide (M A20.6), 4-{[(6-Bromopyrid-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-on (A20.7), 4-{[(6-Fluoropyrid-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5H)-on (A20.8), 4-{[(2-Chloro-1,3-thiazolo-5-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-on (A20.9), 4-{[(6-Chloropyrid-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-on (A20.10), 4-{[(6-Chloropyrid-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5H)-on (A20.11), 4-{[(6-Chloro-5-fluoropyrid-3-yl)methyl](methyl)amino}furan-2(5H)-on (A20.12), 4-{[(5,6-Dichloropyrid-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-on (A20.13), 4-{[(6-Chloro-5-fluoropyrid-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-on (A20.14), 4-{[(6-Chloropyrid-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-on (A20.15), 4-{[(6-Chloropyrid-3-yl)methyl](methyl)amino}furan-2(5H)-on (A20.16), Cyclopropaneacetic acid, 1,1′-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2-cyclopropylacetyl)oxy]methyl]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl]ester (A20.17), and 8-(2-Cyclopropylmethoxy-4-methyl-phenoxy)-3-(6-methyl-pyridazin-3-yl)-3-aza-bicyclo[3.2.1]octane (A20.18), in synergistically effective amounts.